Select a Region North America

Expertise

Danny Williams

Channel Management and Compliance

专长:

Global Channel Management & 3PL

With more than two decades of account management, business development, and sales experience, Danny is well suited to lead the channel services team at EVERSANA.

He has partnered with clients to develop solutions to increase market share, cut costs, and increase revenue in today’s complex and ever-changing marketplace.

Danny’s prior experience includes pharmaceutical account management on both the pharma and agency sides of the industry, as well as sales analytics and project management roles in global consumer businesses.

He holds an MBA from Mississippi College and a BBA from the University of Mississippi.

Articles by Danny Williams

From Limitations to Expansions: How Prioritizing Patients’ Speed to Therapy Drives Therapy Adoption

Navigating the launch of a new product is a complex and ever-evolving journey for manufacturers. With hundreds of millions of dollars and an abundance of other significant resources invested in a product’s pre-launch commercialization efforts, meeting launch expectations is vital to ensure success and viability, and, most importantly, effectively provide treatment to patients in need. […]

Trade & Channel Strategies: Partnership Pavilion Panel

Panel Summary: The challenges of commercialization are abundant. Now more than ever, the right partner and understanding the patient journey are pivotal to commercialization success and ensuring patient access to therapy. During this panel, EVERSANA, EVOKE and UpScriptHealth experts discuss the launch and later pivot in strategy of a novel therapy. Speed to therapy initiation […]

Pharmaceutical Distribution – Right-Sizing the Channel Strategy for Maximum Impact

In recent years, there has been increasing appetite among manufacturers — and growing capabilities among specialized channel-distribution service providers — to shorten the value chain. When drug manufacturers reflexively commit to a distribution model that is too cumbersome, they forfeit the flexibility needed to increase efficiency, maximize return on investment and minimize risk on a […]

Ask the Expert: e-Commerce Solutions for Channel Management

Many manufacturers involuntarily commit to convoluted, costly distribution models that often lack the flexibility needed to increase efficiency, maximize investments and minimize risk on a product-by-product basis. In this traditional model of working exclusively with large wholesalers and specialty distributors, they are incurring high fees to ensure channel access to pharmacies, hospitals and providers. Throughout […]

Ensuring Speed, Scale and Certainty in Supply Chain

Every twist and turn in the bench-to-bedside commercialization journey introduces increasing regulatory complexity, product-specific special handling requirements, and evolving industry guidelines. With more than 300 client case studies to draw from, we’ve found three opportunities (or pitfalls) that manufacturers must address in their channel distribution strategy: How quickly can you get your product into your […]

Breaking the Cycle of Supply Chain Complexity

As the industry evolves with new regulatory guidelines and product-specific handling requirements, manufacturers now require an agile business model with integrated distribution services. In his new point of view article, Danny Williams, explains how manufacturers can break the cycle of complexity within the supply chain to better connect patients to therapy, leverage distribution operations to […]

Navigating the Cycle of Supply Chain Complexity

As the industry evolves with new regulatory guidelines and product-specific handling requirements, manufacturers now require an agile business model with integrated distribution services. In his new point of view article, Danny Williams, explains how manufacturers can break the cycle of complexity within the supply chain to better connect patients to therapy, leverage distribution operations to […]

Navigating Channel Distribution in a New (and more complex) Biopharma World

Every twist and turn in the bench-to-bedside commercialization journey introduces increasing regulatory complexity, product-specific special handling requirements, and evolving industry guidelines. With more than 300 client case studies to draw from, we’ve found three opportunities (or pitfalls) that manufacturers must address in their channel distribution strategy: How quickly can you get your product into your […]

Interested in scheduling a meeting or speaking event?

联系我们